The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer

Pathology. 2024 Feb;56(1):122-124. doi: 10.1016/j.pathol.2023.06.002. Epub 2023 Aug 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Breast Neoplasms* / diagnosis
  • Female
  • Humans
  • Immunohistochemistry
  • Receptor, ErbB-2
  • Staining and Labeling

Substances

  • Receptor, ErbB-2